Genencor, Brain in Metagenomic Collaboration | GenomeWeb
NEW YORK (GenomeWeb News) — German biotech company Brain AG and Genencor will collaborate to use metagenomics and metabolic pathway engineering to develop enzymes and biosynthetic pathways for use in developing products that could be used to replace petrochemicals in products such as biofuels, plastics, rubber, adhesives, and cosmetics, Genencor said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.